Literature DB >> 17266554

Exploiting structurally diverse nucleoside analogs as probes of reverse transcription complexes.

Jason W Rausch1, Stuart F J Le Grice.   

Abstract

Crystal structures of HIV-1 reverse transcriptase (RT) in complex with either duplex DNA or an RNA/DNA hybrid have provided significant insights into the manner in which this highly versatile enzyme accommodates the conformationally-distinct nucleic acid substrates encountered during the reverse transcription cycle. Biochemical data likewise suggest that unique structural features of the nucleic acid substrates contribute towards recognition by their cognate RT. While site-directed mutagenesis of catalytically- and structurally-critical protein motifs is relatively facile, understanding how nucleic acid structure contributes to its recognition presents a greater challenge. The relative ease with which large DNA and RNA fragments can now be chemically synthesized, in conjunction with the increased availability of ribo- and deoxyribonucleoside analogs, allows nucleic acid structure to be examined with respect to the role of hydrogen bonding, nucleobase stacking, sugar ring geometry and charge of the phosphodiester backbone. This review summarizes our use of nucleoside analogs to understand how the structure of cis-acting regulatory signals mediates their recognition by structurally diverse retroviral and retrotransposon enzymes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266554     DOI: 10.2174/157016207779316332

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  2 in total

1.  Probing the active site steric flexibility of HIV-1 reverse transcriptase: different constraints for DNA- versus RNA-templated synthesis.

Authors:  Adam P Silverman; Scott J Garforth; Vinayaka R Prasad; Eric T Kool
Journal:  Biochemistry       Date:  2008-03-27       Impact factor: 3.162

2.  Analysis of RNA base modification and structural rearrangement by single-molecule real-time detection of reverse transcription.

Authors:  Igor D Vilfan; Yu-Chih Tsai; Tyson A Clark; Jeffrey Wegener; Qing Dai; Chengqi Yi; Tao Pan; Stephen W Turner; Jonas Korlach
Journal:  J Nanobiotechnology       Date:  2013-04-03       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.